Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network Trial.

Kenneth W. Mahaffey, Matthew T. Roe, Christopher K. Dyke, L. Kristin Newby, Neal S. Kleiman, Patty Connolly, Lisa G. Berdan, Rodney Sparapani, Kerry L. Lee, Paul W. Armstrong, Eric J. Topol, Robert M. Califf, Robert A. Harrington

Research output: Contribution to journal › Article › peer-review

71 Scopus citations

Fingerprint

Dive into the research topics of 'Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network Trial.'. Together they form a unique fingerprint.

Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network Trial.

Fingerprint

Keyphrases

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology